• Nem Talált Eredményt

18 eredmény a kulcsszóra: 'randomized controlled clinical trial'

MagyAR ONKOLÓGUSOK Társasága www.WEBIO.huMagyar Onkológia 50. évfolyam 1. szám 2006

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy

Protected

N/A

6
0
0
2022
A guidingkatéter szerepe a thrombusaspiráció  hatékonyságának növelésében: Esetismertetés

According to recent randomized controlled clinical trials (TASTE [Thrombus Aspiration in ST-Elevation Myocardial Infarction in Scandinavia] and TOTAL [Trial of Routine

Protected

N/A

4
0
0
2022
CHEMICAL CHARACTERISATION AND XRD STUDY OF ZIRCONOLITE FROM HÅKESTAD ALKALINE PEGMATITE, LARVIK PLUTONIC COMPLEX, SOUTH NORWAY

CHEMICAL CHARACTERISATION AND XRD STUDY OF ZIRCONOLITE FROM HÅKESTAD ALKALINE PEGMATITE, LARVIK PLUTONIC COMPLEX, SOUTH NORWAY.. HAIFLER, J.* &

Protected

N/A

1
0
0
2022
POLAR Study Revisited: Therapeutic Hypothermia in Severe Brain Trauma Should Not Be Abandoned

In December 2018, the Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury (POLAR), a multi-center randomized controlled trial, appeared to end the debate by showing that

Protected

N/A

5
0
0
2022
Status Update and Interim Results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2)

Asymptomatic Ca- rotid Surgery Trial-2 (ACST-2): rationale for a randomized clinical trial comparing carotid endarterectomy with carotid artery stenting in patients with

Protected

N/A

9
0
0
2022
Status Update and Interim Results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2)

Asymptomatic Ca- rotid Surgery Trial-2 (ACST-2): rationale for a randomized clinical trial comparing carotid endarterectomy with carotid artery stenting in patients with

Protected

N/A

9
0
0
2022
Vasovagalis syncope gyermekkorban Dr. Rudas László Szegedi Tudományegyetem II. sz. Belgyógyászati Klinika és Kardiológiai Központ Belgyógyászati Intenzív osztály

Permanent (cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multicenter, randomized, controlled trial. Benditt DG, Ferguson DW, Grubb BP,

Protected

N/A

9
0
0
2022
The IFNB Multiple Sclerosis Study Group

Interferon beta-lb is effective in relapsing-remitting multiple sclerosis MRI analysis results of a multicentre, randomized, double-blind, placebo controlled trial.. A kopolimer

Protected

N/A

2
0
0
2022
Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal

Indeed, inspired by their previous results, the same French group conducted a randomized, double-blind, controlled noninferiority withdrawal trial to confirm their observation that

Protected

N/A

19
0
0
2022
A zenei teljesítményszorongás (lámpaláz) kezelési és preventív módszerei

Acceptance and Commitment Therapy ve rsus Cognitive Behavior Therapy for Children With Anxiety: Outcomes of a Randomized Controlled Trial.. Acceptance and commitment therapy and

Protected

N/A

12
0
0
2022
Aktualitások a nem-melanoma típusú bőrdaganatok helyi kezeléséről és az előrehaladott stádiumú betegek gyógyszeres terápiájárólUpdate on the topical and systemic treatment in non-melanoma skin cancers

és mtsai.: Five- Year Results of a Randomized Controlled Trial Comparing Ef- fectiveness of Photodynamic Therapy, Topical Imiquimod, and To- pical 5-Fluorouracil in Patients

Protected

N/A

8
0
0
2022
Received: 3 September 2019

This study protocol describes the design of a randomized controlled trial with the following aims: (1) evaluate the relationship between user engagement and intervention efficacy,

Protected

N/A

10
0
0
2022
,RenaudLouis andNeilBarnes AliceM.Turner ,LillaTamasi ,FlorenceSchleich ,MehmetHoxha ,IldikoHorvath ClinicallyrelevantsubgroupsinCOPDandasthma

Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical

Protected

N/A

16
0
0
2022
Az IgA-nephropathia terápiája

és mtsai: Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA ne- phropathy: a double-blind randomized controlled trial. J., et al., fot the

Protected

N/A

8
0
0
2022
Krist´ofB´erczi,KarthekeyanChandrasekaran,Tam´asKir´aly,andVivekMadan ImprovingtheIntegralityGapforMultiwayCut

In this section, we summarize the relevant background about the gap instance against non-opposite 3-way cuts designed by Angelidakis, Makarychev and Manurangsi [1].. For our

Protected

N/A

34
0
0
2022
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial

Findings In this nonprespecified, post hoc analysis of the GLOBAL LEADERS randomized clinical trial, beyond 1 month after percutaneous coronary intervention in acute coronary

Protected

N/A

10
0
0
2022
The Merit of Histological Evaluation of Clinically Successful Reconstructive Therapies in Periodontology and Related Fields

(2012) A phase IIa randomized controlled pilot study evaluating the safety and clinical outcomes following the use of rhGDF-5/β-TCP in regenerative periodontal

Protected

N/A

133
0
0
2022
Randomized controlled resistance training based physical activity trial for central European nursing home residing older adults

(Cite this article as: Barthalos i, dorgo S, Kopkáné plachy J, Szakály Z, ihász f, ráczné Németh T, et al. randomized controlled resistance training based physical activity trial

Protected

N/A

10
0
0
2022

Töltsön fel további dokumentumokat, és töltse le azonnal az anyagtanulmányokat!